PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 141 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $76,710 | -20.9% | 7,892 | -16.5% | 0.00% | 0.0% |
| Q4 2020 | $97,008 | +1.7% | 9,455 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $95,401 | -5.9% | 9,455 | -2.8% | 0.00% | 0.0% |
| Q2 2020 | $101,421 | +23.6% | 9,724 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $82,071 | -2.7% | 9,724 | +0.9% | 0.00% | +100.0% |
| Q4 2019 | $84,341 | -26.2% | 9,639 | -9.2% | 0.00% | -50.0% |
| Q3 2019 | $114,270 | -3.4% | 10,615 | +14.0% | 0.00% | 0.0% |
| Q2 2019 | $118,330 | -67.2% | 9,310 | 0.0% | 0.00% | -71.4% |
| Q1 2019 | $361,135 | +83.0% | 9,310 | -4.0% | 0.01% | +75.0% |
| Q4 2018 | $197,354 | -53.8% | 9,698 | +4.0% | 0.00% | -50.0% |
| Q3 2018 | $427,505 | -99.9% | 9,324 | 0.0% | 0.01% | -11.1% |
| Q2 2018 | $551,514,000 | -13.1% | 9,324 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $634,498,000 | +69778.6% | 9,324 | +1.5% | 0.01% | -25.0% |
| Q4 2017 | $908,000 | -61.4% | 9,186 | -53.2% | 0.01% | -20.0% |
| Q3 2017 | $2,350,000 | +35.9% | 19,626 | -0.8% | 0.02% | +25.0% |
| Q2 2017 | $1,729,000 | +130.8% | 19,785 | -1.8% | 0.01% | +140.0% |
| Q1 2017 | $749,000 | +21.2% | 20,142 | 0.0% | 0.01% | +25.0% |
| Q4 2016 | $618,000 | -48.5% | 20,142 | +12.6% | 0.00% | -55.6% |
| Q3 2016 | $1,200,000 | +119.4% | 17,895 | -2.6% | 0.01% | +125.0% |
| Q2 2016 | $547,000 | +894.5% | 18,371 | +879.8% | 0.00% | – |
| Q1 2016 | $55,000 | -62.6% | 1,875 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $147,000 | +6.5% | 1,875 | +2.7% | 0.00% | 0.0% |
| Q3 2015 | $138,000 | -35.2% | 1,825 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $213,000 | -95.2% | 1,825 | -90.3% | 0.00% | -97.0% |
| Q1 2015 | $4,433,000 | +31.5% | 18,775 | +5.4% | 0.03% | +43.5% |
| Q4 2014 | $3,370,000 | -20.7% | 17,805 | 0.0% | 0.02% | -25.8% |
| Q3 2014 | $4,248,000 | +246.8% | 17,805 | -4.0% | 0.03% | +244.4% |
| Q2 2014 | $1,225,000 | -36.6% | 18,555 | 0.0% | 0.01% | -30.8% |
| Q1 2014 | $1,932,000 | +4.7% | 18,555 | +4.1% | 0.01% | 0.0% |
| Q4 2013 | $1,846,000 | +104.7% | 17,826 | +6.1% | 0.01% | +85.7% |
| Q3 2013 | $902,000 | +5.5% | 16,807 | -12.7% | 0.01% | 0.0% |
| Q2 2013 | $855,000 | – | 19,263 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
| Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
| PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
| TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
| Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
| Leap Investments LP | 29,100 | $370,000 | 0.50% |
| Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
| Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
| Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |